Data / Drug companies / Benazepril hydrochloride
Benazepril hydrochloride: 24 companies and 88 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Benazepril hydrochloride is listed in the FDA National Drug Code Directory by 24 companies, with 88 products in commercial distribution. 85 of the products (96.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, coated; tablet; tablet, film coated, and the newest product started marketing on July 27, 2026.
The request: Get every company that lists benazepril hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 24
- Products
- 88
- Generic (ANDA) products
- 85 (96.6%)
- Application numbers
- 6
- Routes
- Oral
- Brand names
- Lotensin
- openFDA record search
- api.fda.gov
Companies that list benazepril hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 9 | tablet, coated; tablet, film coated | Generic drugs (ANDA) | January 1, 2014 |
| A-S Medication Solutions | 6 | tablet, film coated; tablet, coated | Generic drugs (ANDA) | January 1, 2014 |
| Bryant Ranch Prepack | 6 | tablet, coated; tablet | Generic drugs (ANDA) | January 1, 2014 |
| Northwind Health Company, LLC | 6 | tablet, film coated; tablet, coated | Generic drugs (ANDA) | May 19, 2023 |
| Preferred Pharmaceuticals Inc. | 5 | tablet, coated; tablet, film coated | Generic drugs (ANDA) | May 19, 2025 |
| Amneal Pharmaceuticals LLC | 4 | tablet | Generic drugs (ANDA) | February 2, 2010 |
| Amneal Pharmaceuticals of New York LLC | 4 | tablet | Generic drugs (ANDA) | September 26, 2022 |
| Ani Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | July 27, 2026 |
| AvPAK | 4 | tablet | Generic drugs (ANDA) | April 28, 2014 |
| Chartwell RX, LLC | 4 | tablet | Generic drugs (ANDA) | August 20, 2022 |
| Golden State Medical Supply, Inc. | 4 | tablet, coated | Generic drugs (ANDA) | February 11, 2004 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | August 20, 2022 |
| Proficient Rx LP | 4 | tablet, coated | Generic drugs (ANDA) | January 1, 2014 |
| Solco Healthcare US, LLC | 4 | tablet, coated | Generic drugs (ANDA) | January 1, 2014 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | January 13, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, coated; tablet, film coated | Generic drugs (ANDA) | January 1, 2014 |
| Validus Pharmaceuticals LLC | 3 | tablet | New drug applications (NDA) | June 21, 1991 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | May 22, 2008 |
| Cardinal Health 107, LLC | 2 | tablet | Generic drugs (ANDA) | April 28, 2014 |
| Proficient Rx LP | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | February 2, 2010 |
| Remedyrepack Inc. | 2 | tablet, coated; tablet | Generic drugs (ANDA) | April 25, 2026 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | February 2, 2010 |
| Direct_Rx | 1 | tablet, coated | Generic drugs (ANDA) | June 12, 2020 |
| Northwind Health Company, LLC | 1 | tablet, coated | Generic drugs (ANDA) | October 2, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, coated | 36 | 40.9% |
| Tablet | 35 | 39.8% |
| Tablet, film coated | 17 | 19.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 85 | 96.6% |
| New drug applications (NDA) | 3 | 3.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin Converting Enzyme Inhibitor | 88 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.